Clinical Trials Browser

Phase 1/2 × enzastaurin × Thoracic × Clear all

NCT00452413 2021-05-13

A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer

Phase 1/2 Completed

65 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung